https://scholars.lib.ntu.edu.tw/handle/123456789/637650
標題: | Study Protocol of a Randomized Controlled Clinical Trial to Evaluate the Efficacy and Safety of Ropeginterferon Alfa-2b in COVID-19 Patients with Comorbidities | 作者: | WANG-DA LIU HSIN-AN HOU KO-JEN LI Qin, Albert Tsai, Chan-Yen WANG-HUEI SHENG |
關鍵字: | Anti-SARS-CoV-2 drugs; Anti-SARS-CoV-2 efficacy; COVID-19; Patients with comorbidities; Randomized clinical trial; Ropeginterferon alfa-2b | 公開日期: | 2024 | 來源出版物: | Advances in therapy | 摘要: | Ropeginterferon alfa-2b represents a new-generation PEGylated interferon. It is approved for the treatment of polycythemia vera and shows promising anti-SARS-CoV-2 activities. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/637650 | ISSN: | 0741238X | DOI: | 10.1007/s12325-023-02715-7 |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。